Ligand Pharmaceuticals
LGND
#3601
Rank
NZ$6.29 B
Marketcap
NZ$320.01
Share price
-1.93%
Change (1 day)
49.68%
Change (1 year)

Market capitalization of Ligand Pharmaceuticals (LGND)

Market cap: NZ$6.29 Billion

As of December 2025 Ligand Pharmaceuticals has a market cap of NZ$6.29 Billion. This makes Ligand Pharmaceuticals the world's 3601th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ligand Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$6.29 B72.16%
2024NZ$3.65 B85.78%
2023NZ$1.96 B10.79%
2022NZ$1.77 B-52.97%
2021NZ$3.77 B70.5%
2020NZ$2.21 B-14.92%
2019NZ$2.60 B-37.99%
2018NZ$4.20 B3.24%
2017NZ$4.06 B32.73%
2016NZ$3.06 B-2.99%
2015NZ$3.16 B137.72%
2014NZ$1.32 B1.47%
2013NZ$1.31 B144.22%
2012NZ$0.53 B79.29%
2011NZ$0.29 B32.65%
2010NZ$0.22 B-35.28%
2009NZ$0.34 B-22.25%
2008NZ$0.44 B-24.6%
2007NZ$0.59 B-61.55%
2006NZ$1.54 B29.73%
2005NZ$1.19 B0.13%
2004NZ$1.19 B-28.03%
2003NZ$1.65 B125.61%
2002NZ$0.73 B-71.7%
2001NZ$2.59 B44.48%
2000NZ$1.79 B37.26%
1999NZ$1.30 B29.6%
1998NZ$1.00 B17.98%
1997NZ$0.85 B27.59%
1996NZ$0.66 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Ligand Pharmaceuticals was reported to be:

NZ$6.29 Billion
by Nasdaq info icon info icon
NZ$6.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$307.49 B 4,782.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$0.36 B-94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.15 B 2,585.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$431.15 B 6,745.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$256.18 B 3,967.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.567 T 24,791.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$183.77 B 2,817.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$16.49 B 161.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$842.14 B 13,270.92%๐Ÿ‡บ๐Ÿ‡ธ USA